Variable, n (%) | Placebo/Edivoxetine N = 195 | Edivoxetine/Edivoxetine N = 93 | All Patients N = 288 |
Patients with at least one TEAE | 176 (90.3) | 79 (85.9) | 255 (88.9) |
Nasopharyngitis | 56 (28.7) | 29 (31.5) | 85 (29.6) |
Tachycardia | 62 (31.8) | 17 (18.5) | 79 (27.5) |
Hyperhidrosis | 33 (16.9) | 16 (17.4) | 49 (17.1) |
Palpitations | 36 (18.5) | 12 (13.0) | 48 (16.7) |
Nausea | 26 (13.3) | 8 (8.7) | 34 (11.9) |
Heart rate increased | 25 (12.8) | 7 (7.6) | 32 (11.2) |
Constipation | 19 (9.7) | 7 (7.6) | 26 (9.1) |
Dizziness | 21 (10.8) | 4 (4.4) | 25 (8.7) |
Headache | 17 (8.7) | 7 (7.6) | 24 (8.4) |
Vomiting | 14 (7.2) | 3 (3.3) | 17 (5.9) |